NDC 65250-260

NDC 65250-260

NDC 65250-260 is a Injection, Suspension, Liposomal in the Drug For Further Processing category. It is labeled and distributed by Pacira Pharmaceuticals Inc..

Product ID65250-260_0577d6c7-5b19-4214-b12f-102c8e7b2d3d
NDC65250-260
Product TypeDrug For Further Processing
Proprietary NameNDC 65250-260
Dosage FormInjection, Suspension, Liposomal
Marketing Start Date2018-09-24
Marketing Category/ DRUG FOR FURTHER PROCESSING
Labeler NamePacira Pharmaceuticals Inc.

Packaging

NDC 65250-260-01

12600 VIAL in 1 PACKAGE (65250-260-01) > 20 mL in 1 VIAL
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
BUPIVACAINE13.3 mg/mL

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.